Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11267801 Therapeutic compounds

Patent 11267801 was granted and assigned to Gilead Sciences on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Gilead Sciences
Gilead Sciences
Date Filed
October 5, 2020
Date of Patent
March 8, 2022
Patent Applicant
Gilead Sciences
Gilead Sciences
Patent Application Number
17062676
Patent Citations
‌
US Patent 10696657 Methods and intermediates for preparing therapeutic compounds
‌
US Patent 10836746 Therapeutic compounds
0
‌
US Patent 11117886 Methods and intermediates for preparing therapeutic compounds
0
‌
US Patent 10849892 Choline salt forms of an HIV capsid inhibitor
‌
US Patent 10071985 Therapeutic compounds
‌
US Patent 10370342 Toll like receptor modulator compounds
0
‌
US Patent 10370358 Compounds for the treatment of HIV
‌
US Patent 10640499 Toll like receptor modulator compounds
0
‌
US Patent 10654827 Therapeutic compounds
Patent Citations Received
‌
US Patent 12084467 Therapeutic compounds for HIV virus infection
0
‌
US Patent 11787825 Therapeutic compounds for HIV virus infection
Patent Inventor Names
Winston C. Tse
0
Chienhung Chou
0
Eda Canales
0
Gediminas Brizgys
0
Jennifer R. Zhang
0
Jiayao Li
0
Michael Graupe
0
Qiaoyin Wu
0
Roland D. Saito
0
Scott D. Schroeder
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11267801
Patent Primary Examiner
‌
Kamal A Saeed

Find more entities like US Patent 11267801 Therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.